HUTCHMED (China) (HCM) Short-term Investments (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Short-term Investments of $1.3 billion for Q2 2026, up 1.15% year-over-year from $1.3 billion in Q2 2025, and down 2.14% quarter-over-quarter from $1.3 billion in Q4 2025.
HUTCHMED (China) (HCM) Short-term Investments (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Short-term Investments for 12 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Short-term Investments rose 1.15% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $1.3 billion (up 1.15% YoY), while the FY2025 annual figure was $1.3 billion, changed N/A from the prior year.
- Short-term Investments fell to $1.3 billion in Q2 2026 per HCM's latest filing, from $1.3 billion in the prior quarter.
- Across five years, Short-term Investments topped out at $1.3 billion in Q4 2025 and bottomed at $317.7 million in Q4 2022.
- Historically, Short-term Investments has averaged $818.0 million across 5 years, with a median of $633.2 million in 2023.
- Annual changes were most pronounced in 2022 — Short-term Investments sank 49.9% — and 2025, when it soared 109.49%.
- HUTCHMED (China)'s Short-term Investments stood at $317.7 million in 2022, then jumped by 99.29% to $633.2 million in 2023, then decreased by 5.48% to $598.5 million in 2024, then jumped by 116.53% to $1.3 billion in 2025, then slipped by 2.14% to $1.3 billion in 2026.
- Business Quant data shows HCM's Short-term Investments at $1.3 billion in Q2 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.30 Bn |
| Jun 30, 2025 | 1.25 Bn |
| Jun 30, 2024 | 598.50 Mn |
| Jun 30, 2023 | 633.17 Mn |
| Dec 31, 2022 | 317.72 Mn |
| Jun 30, 2022 | 358.70 Mn |
| Dec 31, 2021 | 634.16 Mn |
| Jun 30, 2021 | 363.01 Mn |
| Mar 31, 2021 | 49.94 Mn |
| Dec 31, 2020 | 199.55 Mn |
| Jun 30, 2020 | 231.07 Mn |
| Dec 31, 2019 | 96.01 Mn |
| Sep 30, 2019 | 104.49 Mn |
| Jun 30, 2019 | 153.93 Mn |
| Mar 31, 2019 | 180.17 Mn |
| Dec 31, 2018 | 214.92 Mn |
| Jun 30, 2018 | 247.17 Mn |
| Dec 31, 2017 | 273.03 Mn |
| Jun 30, 2017 | 680,000.00 |